Mutational analysis of CCL20 reveals flexibility of N-terminal amino acid composition and length

Sarah J. Riutta, Olav Larsen, Anthony E. Getschman, Mette M. Rosenkilde, Samuel T Hwang, Brian F. Volkman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Chemokine–chemokine receptor (CKR) interactions are traditionally described by a two-step/two-site mechanism that details the major contact points between chemokine ligands and CKRs leading to ligand recognition and receptor activation. Chemokine recognition site 1 (CRS1) encompasses interactions between the CKR N-terminus and the globular chemokine core. Chemokine recognition site 2 (CRS2) includes interactions between the unstructured chemokine N-terminus and the binding pocket of the receptor. The two-step/two-site paradigm has been an adequate framework to study the intricacies of chemokine:CKR interactions, but emerging studies highlight the limitations of this model. Here, we present studies of CRS2 interactions between the chemokine CCL20 and its cognate receptor CCR6 driven by the hypothesis that CCL20 interacts with CCR6 as described by the two-step/two-site model. CCL20 is a chemokine with an unusually short N-terminus of 5 residues (NH2-ASNFD), compared to the average length of 10 residues for chemokine ligands. We have investigated how well CCL20 tolerates manipulation of the N-terminus by monitoring binding affinity of variants and their ability to activate the receptor. We show the CCL20 N-terminus tolerates truncation of up to 3 residues, extension by up to 5 additional residues, and point mutations at 4 of 5 positions with minimal loss of binding affinity and minimal impairment in ability to stimulate calcium mobilization, inositol triphosphate accumulation, chemotaxis, and β-arrestin-2 recruitment. Mutation of the fifth residue, aspartate, to alanine or lysine has a dramatic impact on binding affinity for CCR6 and ligand potency. We postulate CCL20 does not activate CCR6 through the canonical two-step/two-site mechanism of CKR activation.

Original languageEnglish (US)
Pages (from-to)423-434
Number of pages12
JournalJournal of Leukocyte Biology
Volume104
Issue number2
DOIs
StatePublished - Aug 1 2018

Fingerprint

Chemokines
Amino Acids
Ligands
Aptitude
CCR6 Receptors
Chemokine CCL20
Chemokine Receptors
Inositol
Chemotaxis
Point Mutation
Aspartic Acid
Alanine
Lysine
Calcium
Mutation

Keywords

  • CCL20
  • CCR6
  • chemokine
  • chemokine receptor
  • mutagenesis
  • two-step/two-site paradigm

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Cite this

Mutational analysis of CCL20 reveals flexibility of N-terminal amino acid composition and length. / Riutta, Sarah J.; Larsen, Olav; Getschman, Anthony E.; Rosenkilde, Mette M.; Hwang, Samuel T; Volkman, Brian F.

In: Journal of Leukocyte Biology, Vol. 104, No. 2, 01.08.2018, p. 423-434.

Research output: Contribution to journalArticle

Riutta, Sarah J. ; Larsen, Olav ; Getschman, Anthony E. ; Rosenkilde, Mette M. ; Hwang, Samuel T ; Volkman, Brian F. / Mutational analysis of CCL20 reveals flexibility of N-terminal amino acid composition and length. In: Journal of Leukocyte Biology. 2018 ; Vol. 104, No. 2. pp. 423-434.
@article{658991b160eb45f1a91e2b021d0fdead,
title = "Mutational analysis of CCL20 reveals flexibility of N-terminal amino acid composition and length",
abstract = "Chemokine–chemokine receptor (CKR) interactions are traditionally described by a two-step/two-site mechanism that details the major contact points between chemokine ligands and CKRs leading to ligand recognition and receptor activation. Chemokine recognition site 1 (CRS1) encompasses interactions between the CKR N-terminus and the globular chemokine core. Chemokine recognition site 2 (CRS2) includes interactions between the unstructured chemokine N-terminus and the binding pocket of the receptor. The two-step/two-site paradigm has been an adequate framework to study the intricacies of chemokine:CKR interactions, but emerging studies highlight the limitations of this model. Here, we present studies of CRS2 interactions between the chemokine CCL20 and its cognate receptor CCR6 driven by the hypothesis that CCL20 interacts with CCR6 as described by the two-step/two-site model. CCL20 is a chemokine with an unusually short N-terminus of 5 residues (NH2-ASNFD), compared to the average length of 10 residues for chemokine ligands. We have investigated how well CCL20 tolerates manipulation of the N-terminus by monitoring binding affinity of variants and their ability to activate the receptor. We show the CCL20 N-terminus tolerates truncation of up to 3 residues, extension by up to 5 additional residues, and point mutations at 4 of 5 positions with minimal loss of binding affinity and minimal impairment in ability to stimulate calcium mobilization, inositol triphosphate accumulation, chemotaxis, and β-arrestin-2 recruitment. Mutation of the fifth residue, aspartate, to alanine or lysine has a dramatic impact on binding affinity for CCR6 and ligand potency. We postulate CCL20 does not activate CCR6 through the canonical two-step/two-site mechanism of CKR activation.",
keywords = "CCL20, CCR6, chemokine, chemokine receptor, mutagenesis, two-step/two-site paradigm",
author = "Riutta, {Sarah J.} and Olav Larsen and Getschman, {Anthony E.} and Rosenkilde, {Mette M.} and Hwang, {Samuel T} and Volkman, {Brian F.}",
year = "2018",
month = "8",
day = "1",
doi = "10.1002/JLB.1VMA0218-049R",
language = "English (US)",
volume = "104",
pages = "423--434",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "2",

}

TY - JOUR

T1 - Mutational analysis of CCL20 reveals flexibility of N-terminal amino acid composition and length

AU - Riutta, Sarah J.

AU - Larsen, Olav

AU - Getschman, Anthony E.

AU - Rosenkilde, Mette M.

AU - Hwang, Samuel T

AU - Volkman, Brian F.

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Chemokine–chemokine receptor (CKR) interactions are traditionally described by a two-step/two-site mechanism that details the major contact points between chemokine ligands and CKRs leading to ligand recognition and receptor activation. Chemokine recognition site 1 (CRS1) encompasses interactions between the CKR N-terminus and the globular chemokine core. Chemokine recognition site 2 (CRS2) includes interactions between the unstructured chemokine N-terminus and the binding pocket of the receptor. The two-step/two-site paradigm has been an adequate framework to study the intricacies of chemokine:CKR interactions, but emerging studies highlight the limitations of this model. Here, we present studies of CRS2 interactions between the chemokine CCL20 and its cognate receptor CCR6 driven by the hypothesis that CCL20 interacts with CCR6 as described by the two-step/two-site model. CCL20 is a chemokine with an unusually short N-terminus of 5 residues (NH2-ASNFD), compared to the average length of 10 residues for chemokine ligands. We have investigated how well CCL20 tolerates manipulation of the N-terminus by monitoring binding affinity of variants and their ability to activate the receptor. We show the CCL20 N-terminus tolerates truncation of up to 3 residues, extension by up to 5 additional residues, and point mutations at 4 of 5 positions with minimal loss of binding affinity and minimal impairment in ability to stimulate calcium mobilization, inositol triphosphate accumulation, chemotaxis, and β-arrestin-2 recruitment. Mutation of the fifth residue, aspartate, to alanine or lysine has a dramatic impact on binding affinity for CCR6 and ligand potency. We postulate CCL20 does not activate CCR6 through the canonical two-step/two-site mechanism of CKR activation.

AB - Chemokine–chemokine receptor (CKR) interactions are traditionally described by a two-step/two-site mechanism that details the major contact points between chemokine ligands and CKRs leading to ligand recognition and receptor activation. Chemokine recognition site 1 (CRS1) encompasses interactions between the CKR N-terminus and the globular chemokine core. Chemokine recognition site 2 (CRS2) includes interactions between the unstructured chemokine N-terminus and the binding pocket of the receptor. The two-step/two-site paradigm has been an adequate framework to study the intricacies of chemokine:CKR interactions, but emerging studies highlight the limitations of this model. Here, we present studies of CRS2 interactions between the chemokine CCL20 and its cognate receptor CCR6 driven by the hypothesis that CCL20 interacts with CCR6 as described by the two-step/two-site model. CCL20 is a chemokine with an unusually short N-terminus of 5 residues (NH2-ASNFD), compared to the average length of 10 residues for chemokine ligands. We have investigated how well CCL20 tolerates manipulation of the N-terminus by monitoring binding affinity of variants and their ability to activate the receptor. We show the CCL20 N-terminus tolerates truncation of up to 3 residues, extension by up to 5 additional residues, and point mutations at 4 of 5 positions with minimal loss of binding affinity and minimal impairment in ability to stimulate calcium mobilization, inositol triphosphate accumulation, chemotaxis, and β-arrestin-2 recruitment. Mutation of the fifth residue, aspartate, to alanine or lysine has a dramatic impact on binding affinity for CCR6 and ligand potency. We postulate CCL20 does not activate CCR6 through the canonical two-step/two-site mechanism of CKR activation.

KW - CCL20

KW - CCR6

KW - chemokine

KW - chemokine receptor

KW - mutagenesis

KW - two-step/two-site paradigm

UR - http://www.scopus.com/inward/record.url?scp=85050596102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050596102&partnerID=8YFLogxK

U2 - 10.1002/JLB.1VMA0218-049R

DO - 10.1002/JLB.1VMA0218-049R

M3 - Article

C2 - 30114340

AN - SCOPUS:85050596102

VL - 104

SP - 423

EP - 434

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 2

ER -